| # | Drug | Count |
|---|---|---|
| 0 | ASFOTASE ALFA | 113 |
| 1 | DENOSUMAB | 99 |
| 2 | ACETAMINOPHEN | 68 |
| 3 | ERGOCALCIFEROL | 66 |
| 4 | FINGOLIMOD HCL | 65 |
| 5 | PREDNISONE | 62 |
| 6 | METHOTREXATE SODIUM | 50 |
| 7 | ACETAMINOPHEN 500MG | 47 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 47 |
| 9 | PAIN RELIEVER | 47 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE AND MAGNESIUM CHLORIDE | 1 | 0.0169 |
| 1 | DEXTROSE AND SODIUM CHLORIDE | 2 | 0.0120 |
| 2 | ASFOTASE ALFA | 113 | 0.0109 |
| 3 | BORON | 3 | 0.0100 |
| 4 | ESMOLOL HYDROCHLORIDE IN SODIUM CHLORIDE | 1 | 0.0086 |
| 5 | ONASEMNOGENE ABEPARVOVEC-XIOI | 13 | 0.0056 |
| 6 | DICLOFENAC SODIUM/MISOPROSTOL | 2 | 0.0045 |
| 7 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 8 | FLUOROMETHOLONE ACETATE | 1 | 0.0037 |
| 9 | ESMOLOL HYDROCHLORIDE | 1 | 0.0037 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 139 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 123 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 113 |
| 3 | RANK Ligand Inhibitor [EPC] | 99 |
| 4 | Provitamin D2 Compound [EPC] | 66 |
| 5 | Benzodiazepine [EPC] | 64 |
| 6 | Vitamin C [EPC] | 48 |
| 7 | Kinase Inhibitor [EPC] | 46 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 42 |
| 9 | Proton Pump Inhibitor [EPC] | 38 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 113 | 0.0109 |
| 1 | Provitamin D2 Compound [EPC] | 66 | 0.0022 |
| 2 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 3 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 1 | 0.0013 |
| 4 | Plasma Volume Expander [EPC] | 4 | 0.0013 |
| 5 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 6 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 7 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 1 | 0.0011 |
| 8 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 9 | Vasopressin V2 Receptor Antagonist [EPC] | 12 | 0.0008 |